Tag: medication-assisted treatment
February 7, 2018
Press Release, February 7, 2018
Today, the Substance Abuse and Mental Health Services Administration (SAMHSA) released new Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants.
SAMHSA’s Clinical Guidance comes at a time of great need for effective opioid use disorder (OUD) treatment. In 2016, over 20,000 pregnant women reported using heroin or misusing pain relievers in the past month. Newborn babies of mothers who used opioids while pregnant are at risk of neonatal abstinence syndrome–a group of physical and neurobehavioral signs of withdrawal.
January 30, 2018
Node Investigators Launch Purple Pod to Augment Care for Pregnant Women on Buprenorphine
This past September, Dartmouth-Hitchcock Medical Center’s (DHMC; Lebanon, NH) Division of Obstetrics and Gynecology (OB/GYN) implemented the Purple Pod – a division of OB/GYN that provides weekly clinics for patients with pregnancies complicated by substance use disorders (SUDs) who are receiving medication-assisted treatment (MAT) from providers outside of the hospital’s “Moms in Recovery” program.
December 9, 2017
Catholic Medical Center hosts 3rd annual Summit on Treating Opiate-Dependent Patients
In November, our partner at Catholic Medical Center (CMC) hosted its third annual Summit on Treating Opiate-Dependent Patients. The annual Summit brings together physicians, dentists, podiatrists, nurse practitioners, physician assistants, other prescribers, nurses, social workers, allied health professionals, pharmacists, social service agencies, law enforcement, first responders and other stakeholders to discuss New Hampshire’s opioid epidemic.